EcoDrugPlus

Adrenoceptor Beta 1

Ensembl ID : ENSCHOG00000010143
Gene Symbol: ADRB1
1 Cross references
163 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSCHOG00000009765
Gene Symbol: AGER
1 Cross references
170 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSCHOG00000011779
Gene Symbol: ADH5
1 Cross references
410 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSCHOG00000001868
Gene Symbol: AKR1B1
1 Cross references
426 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSCHOG00000000638
Gene Symbol: APCS
1 Cross references
402 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSCHOG00000006659
Gene Symbol: APP
1 Cross references
279 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSCHOG00000004336
Gene Symbol: AGTR1
1 Cross references
214 Possible Orthologues:

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSCHOG00000007215
Gene Symbol: APH1B
1 Cross references
193 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSCHOG00000007322
Gene Symbol: AHR
1 Cross references
155 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSCHOG00000010758
Gene Symbol: BACE1
1 Cross references
220 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSCHOG00000007384
Gene Symbol: CALCRL
1 Cross references
149 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSCHOG00000013449
Gene Symbol: CASR
1 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).